10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine

Catalog No. :
ACXMQT560
CAS No. :
3159-07-7
Molecular Formula :
C13H9NOS
Molecular Weight :
227.29

IUPAC Name:dibenzo[b,f][1,4]thiazepin-11(10H)-one

10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$56.00Login to see priceIn stockInquiry
500g98%$167.00Login to see priceIn stockInquiry
1000g98%$333.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
IUPAC Namedibenzo[b,f][1,4]thiazepin-11(10H)-one
MDL No.MFCD00901197
Molecular FormulaC13H9NOS
Molecular Weight227.29
SMILESC1=CC=CC2=C1C(NC3=C(S2)C=CC=C3)=O
InChI KeyRTERDTBXBYNZIS-UHFFFAOYSA-N
Synonym1-(2,3-Dimethyl-1H-indol-6-yl)-N,N-dimethylmethanamine | Dibenzo[b,f][1,4]thiazepin-11(10H)-one | MFCD00901197 | O10365 | Dibenzo[b,f][1,4]thiazepin-11(10H)-one # | QUETIAPINE FUMARATE IMPURITY G [EP IMPURITY] | DS-0806 | Dibenzo[b,f][1,4]thiazepin-11(10H
CAS No.3159-07-7
PubChem CID374829

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXMQT560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIPG589 route compound structure diagram
    ACLIPG58954920-98-8 In Stock
  2. Then
  3. ACXMQT560 route product structure diagram
    ACXMQT5603159-07-7 In Stock
Inquiry

2. ACXMQT560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACXMQT560 route product structure diagram
    ACXMQT5603159-07-7 In Stock
Inquiry

Comments (0)